Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes and Stage 3 Chronic Kidney Disease. Cherney DZI, Ferrannini E, Umpierrez GE, Peters AL, et al. Diabetes Obes Metab 2023 Feb 13. doi: 10.1111/dom.15019.

Read + Share

Amedeo Smart

Independent Medical Education

Cherney DZI, Ferrannini E, Umpierrez GE, Peters AL, et al. Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes and Stage 3 Chronic Kidney Disease. Diabetes Obes Metab 2023 Feb 13. doi: 10.1111/dom.15019.
PMID: 36782093